Comparing interventions with network meta-analysis by Bagg, Matthew K et al.
Appraisal
Research Note: Comparing interventions with network meta-analysis
Physiotherapists have become familiar with using research
ﬁndings to inform practice. A physiotherapist who is interested in
using research ﬁndings to determine the best physiotherapy
intervention for a patient with osteoarthritis of the knee might
look for high-quality systematic reviews of randomised, controlled
trials (RCTs). A search of PEDro (https://www.pedro.org.au) would
identify a Cochrane systematic review1 on the efﬁcacy of exercise
for patients with osteoarthritis of the knee. The review provides
high-quality evidence that exercise reduces pain and moderate-
quality evidence that exercise improves physical function when
compared with not exercising.
However, the results of a systematic review that compares only
two interventions may not provide all the information required to
make a clinical decision. The clinician, for example, may be
interested in discriminating between ﬂexibility and aerobic
exercise for osteoarthritis. The osteoarthritis systematic review
is not helpful for this purpose because it excluded RCTs that
compared exercise interventionswith each other. To get an answer,
the clinician may compare the beneﬁt of ﬂexibility exercise
compared with no exercise to the beneﬁt of aerobic exercise
compared with no exercise. Such an indirect comparison, which is
not obtained from a single RCT, is valid under certain
assumptions.2–5 If these assumptions are not fulﬁlled, the indirect
comparison may lead to biased conclusions.
Based on the notion of indirect comparison, a new type of
evidence synthesis has emerged over the last 20 years to address
this challenge. Network meta-analysis compares several available
interventions for a clinical problem with each other in a single
meta-analysis. The analysed comparisons may include compar-
isons between interventions that have not been directly compared
in RCTs.2,5–9A league table of the interventions in the network,
displaying all possible pairwise relative effect sizes, can be used to
compare and rank the interventions according to efﬁcacy,
acceptability or safety. This provides critical information to inform
clinical decision-making.
The ﬁeld of network meta-analysis has developed rapidly.10–13
Network meta-analysis has far-reaching relevance to clinicians,
researchers,guideline-developers, regulatorsandpolicy-makers.14–16
The purpose of this Research Note is to provide a user-friendly
overview of the principles and assumptions that underlie network
meta-analysis.
What is a network of interventions?
The central element of network meta-analysis is the network,
which distinguishes it from conventional pairwise meta-analyses.
Networks display the evidence of the effectiveness of interventions
for a clinical condition. For example, a network might display
evidence of the effectiveness of exercise interventions for hip or
knee osteoarthritis,17 non-pharmacological interventions for
cancer-related fatigue,18 or non-operative treatment for chronic
calciﬁc shoulder tendinopathy.19A network consists of nodes and
edges. Each node in the network represents an intervention. Each
edge (a line between two nodes) represents a comparison between
two interventions that has been evaluated in at least one RCT. If
there is no edge between two nodes, no data from RCTs have
compared these interventions. In this way, the network displays all
the available comparisons in the evidence base and alludes to all
the possible comparisons.
Network construction
Multiple factors contribute to network construction. For
researchers conducting a network meta-analysis, a key step is
determining the PICOS (Participants, Interventions, Comparisons,
Outcomes and Study types). The descriptions of the participants (P)
and the comparisons (C) to be studied inﬂuencewhich RCTswill be
included and, hence, the presence and size of the edges in the
network. The interventions (I) are the nodes in the network. The
selection of outcomes (O) is important, as trials without certain
outcomes will not be included in the network meta-analysis for
that outcome. Network meta-analysis is usually performed using
RCTs (S), although methods exist to incorporate non-randomised
data.20 In the networks of interventions for chronic calciﬁc
shoulder tendinopathy,19 the width of each edge reﬂects the
number of trials for that comparison, each node represents an
intervention, and the node diameter is proportional to the number
of participants allocated to that treatment. It is also shown that the
network structure changes according to outcome (Figure 1).
The multiple treatment comparison
The network displays the number of available direct compar-
isons; comparisons for which there are RCT data available. The
absent comparisons, termed indirect comparisons, have no RCT
data available. The relative treatment effects for these comparisons
will be indirectly estimated in network meta-analysis. A system-
atic review is critical to ensure that all the available direct
comparisons are included in the network. Clinicians reading a
network meta-analysis article should be satisﬁed that a rigorous
systematic review was performed. There are several guides
available for this purpose.21–24
Making a comparison between interventions in a network
The idea of combining indirect with direct evidence (when the
latter is available) characterises network meta-analysis. To
illustrate this, a hypothetical example is used. Three interventions
form the simplest possible network of three nodes (Figure 2a).
A clinician may want to know the effects of these three
interventions compared with each other on a continuous
outcome, so that the most effective intervention can be provided
to a patient. Studies comparing A with B (AB), when synthesised,
would produce a standardised mean difference for the direct
comparison AB (SMDABDirect) and studies comparing C with B (CB)
would produce SMDCBDirect. If the comparison between A and C
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(AC) has not been tested in a clinical trial, as Figure 2a indicates,
the network meta-analysis model estimates the ‘missing’ relative
treatment effect of AC by using the AB and CB data to estimate an
indirect effect of AC as SMDACIndirect = SMDABDirect  SMDCBDirect
(Figure 2b). This is called an indirect treatment comparison.
If there are studies directly comparing intervention A and C,
their synthesis will provide a SMDACDirect. The two estimates,
SMDACDirect and SMDACIndirect can be synthesised as a weighted
average to provide SMDACMixed. This is called a mixed treatment
comparison. In more complex network structures, all of the other
direct comparisons in the network will contribute information to
this estimate.25–27 Thus, network meta-analysis estimates are
weighted sums of all direct and indirect comparisons present in
the network. The weighting is inﬂuenced by precision, as in
pair-wise meta-analysis, and network structure.25,27
Assumptions underlying indirect comparison and networkmeta-
analysis
All statistical models require assumptions about the data and
the underlying parameters. The validity of network meta-analysis
depends on the assumption of transitivity. A joint synthesis of the
data in the network is valid only if the included studies are similar
in all important characteristics except for the interventions being
tested.5,11 This is also equivalent to the assumption that a
participant included in any trial could, in principle, be randomised
[(Figure_1)TD$FIG]
Figure 1. Network plots of interventions for chronic calciﬁc shoulder tendinopathy, displayed according to three outcomes (reproduction from Wu et al 19).
Reproduced with permission. Figure label size increased from original. Original material available at doi: 10.1016/j.apmr.2017.02.030. Copyright 2017 by the American
Congress of Rehabilitation Medicine.
UGN = ultrasound-guided needling, RSW = radial extracorporeal shockwave therapy, H-FSW = high-energy focused extracorporeal shockwave therapy,
TENS = transcutaneous electrical nerve stimulation, CG = control group (sham treatment or physiotherapy alone), L-FSW = low-energy focused extracorporeal
shockwave therapy.
[(Figure_2)TD$FIG]
Figure 2. A simple three-node network comparing three interventions.
SMD = standardised mean difference.
Appraisal Research Note 129
to receive any of the interventions in a network. In the hypothetical
example (Figure 2), a valid estimation of SMDACMixed requires that
the three groups of studies – AB, CB and AC – are similar with
respect to relevant effectmodiﬁers (characteristics thatmight alter
the relative treatment effects).
Transitivity is not a binary construct – present or not– therewill
be a degree of conﬁdence inwhether the assumption has beenmet.
Conﬁdence in the assumption is important because it reﬂects the
extent to which the results from the evidence in the network are
likely to be free from confounding (eg, see references28–30).
Researchers conducting a network meta-analysis should think
carefully about the process they will use to ensure that the
transitivity assumption is likely to hold. This should begin at
protocol stage11 where, again, setting the PICOS is important.
Setting narrow criteria for the eligible participants, study settings
and included interventions make the transitivity assumption more
plausible, yet may result in networks that are sparse or
disconnected and cannot be analysed. In the protocol, potential
effect modiﬁers should be listed. Then, in the review, the
distribution of the effect modiﬁers across the network should
be assessed and described. The interested reader is referred to
descriptions of how to assess transitivity from the perspectives of a
user of network meta-analysis21,24 and a researcher conducting
network meta-analysis.5,10,11,26
The network meta-analyses for chronic calciﬁc shoulder
tendinopathy19 excluded rotator cuff tears. This is an example
of a relatively narrow deﬁnition of inclusion criteria. It is possible
that people with rotator cuff tears respond differently to the
interventions studied in the network meta-analysis. The presence
of the covariate (rotator cuff tear) may confound the network
meta-analysis estimates if the covariate is not equally distributed
across all the comparisons in the network. The narrow inclusion
criteria prevent this altogether by excluding the covariate from
the network.
Hilﬁker et al assessed the distribution of the covariate ‘allocation
concealment’acrossthenetworksof interventionsforcancer-related
fatigue.18 Inadequate allocation concealment is associatedwith trial
effect estimates.31,32 In a network meta-analysis, this will introduce
bias if the covariate is not evenly distributed across the studies
grouped by comparison. A balanced distribution controls for the
inﬂuence of the covariate. Methods for assessing the distribution of
covariates are described in two studies.26,33
Heterogeneity and inconsistency in network meta-analysis
As in conventional meta-analysis, heterogeneity is an impor-
tant consideration. However, there is a further consideration in
network meta-analysis: inconsistency. Inconsistency and hetero-
geneity are inter-related.5 Both should be considered and the
results should be interpreted after accounting for their magni-
tudes. Here, the next section focuses on describing the simplest
form of inconsistency and the reader is referred for further detail to
the technical literature.10,11,34,35
Inconsistency is associated with violation of the transitivity
assumption and could be described as a signal in the data that the
various pieces of evidence – direct and indirect – do not ﬁt
together. In its simplest form, inconsistency is present when the
direct estimate for a comparison (eg, SMDACDirect) differs beyond
chance from the indirect estimate (eg, SMDACIndirect). It follows that
a statistical evaluation of inconsistency is possible only in the
presence of direct and indirect evidence for the same compari-
son.10 An inconsistency factor can be estimated as SMDACDir-
ect  SMDACIndirect and the assumption that inconsistency is 0 can
be tested using a Z-test.4,36
It is important to know that the magnitude of heterogeneity –
the method used to estimate it in the network meta-analysis
model, researcher analytic choices37–39 and covariate values in
advancedmodels40 –will inﬂuence detection of inconsistency. The
low power of the tests for inconsistency in many applica-
tions27,37,38,41[2_TD$DIFF]means that a non-signiﬁcant test does not guarantee
that the assumptions underlying network meta-analysis are met.
Clinicians reading network meta-analysis articles should make
sure that several tests and measures of inconsistency10,11,42 are
performed and described. Researchers should follow these
practices43 and interpret results with caution, particularly if the
number of studies is small.
Of the current examples, the network meta-analysis of
interventions for chronic calciﬁc shoulder tendinopathy19 used
[(Figure_3)TD$FIG]
Figure 3. Network meta-analysis summary standardised mean differences (SMD); non-pharmaceutical treatments versus control (usual care) for cancer-related fatigue
(reproduction from Hilﬁker et al 18).
Original material available under Public License (CC BY-NC 4.0) at doi: 10.1136/bjsports-2016-096422. Copyright article author (or their employer) 2017. Material has been
adapted (ﬁgure cropped and title changed) from the original.
CBT = cognitive behavioural therapy, CrI = credible interval, SMD = standardised mean difference, SUCRA = surface under the cumulative ranking curve.
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the recommended approach of applying several tests of
inconsistency. The authors used an omnibus test of inconsistency
(the design-by-treatment test41), as well as the ‘loop-speciﬁc’4
and ‘node-splitting’44 approaches to assess inconsistency
associated with speciﬁc comparisons. Hilﬁker et al used the
node-splitting model in their analysis of interventions for cancer-
related fatigue,18 and Uthman et al used the loop-speciﬁc
approach in their analysis of exercise interventions for knee or
hip osteoarthritis.17 Single tests and measures are not ideal
because the high heterogeneity observed in these networks may
cause spurious results.
Why perform a network meta-analysis?
Network meta-analysis is a statistical method for comparing
multiple treatments. The formalised process of making an indirect
comparison between interventions – particularly the speciﬁcation
and evaluation of assumptions – conveys the extent to which the
results from the joint synthesis of evidence could be subject to bias.
Network meta-analysis uses the entire evidence base to construct
the estimates of effect, which may reduce research waste. Each
network meta-analysis estimate incorporates direct and indirect
evidence and, hence, is more precise than estimates from direct
studies alone.3,7,8,45–49
Synthesis of the entire evidence base with network meta-
analysis is advantageous for decision-making. The availability of
effect estimates for each comparison is informative; however, an
added advantage of networkmeta-analysis is the establishment of a
hierarchy of interventions. Figure 3 displays a network meta-
analysis forest plot, which in contrast to a conventional forest plot
displays the effect size for each intervention compared to a
reference. The effect sizes for all comparisons are listed in league
tables, for example.17 Ranking probabilities can be used to produce
probabilistic statements about the relative advantage of
an intervention compared to all other alternatives (the SUCRA
in Figure 3). Often, these are presented for multiple relevant
outcomes, for example, the effect of exercise onpain andon function
(Figure 4).
Limitations of network meta-analysis?
Networkmeta-analysis can now be ﬁtted in standard statistical
software, such as Stata and R and is becoming increasingly popular.
For advanced, related, techniques like network meta-regression,
which are often needed in applications, it is necessary to employ
more ﬂexible models and techniques that are not accessible to
most non-statisticians (eg, hierarchical models ﬁtted in a Bayesian
framework). Nevertheless, the main challenge in the process is the
evaluation of the assumption underlying network meta-analysis.
Transitivity is a signiﬁcant and often strong assumption. Whilst a
robust argument can often be made for transitivity, it can never be
proven because participants cannot actually be randomisedwithin
the indirect comparisons. This means that despite rigorous
attention, for example using directed acyclic graphs,50 unobserved
confounding may still bias the estimates.5,50
Summary
Network meta-analysis is the ‘next generation evidence
synthesis tool’.11 Physiotherapy practice and research stands to
beneﬁt from the powerful features of the methodology. Yet,
network meta-analysis relies on key assumptions in study design
and analysis. Physiotherapists should understand these assump-
tions and ensure they are met in the network meta-analyses that
they use or perform.
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